Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze prophylaxis in pediatric HAE
NCT02052141Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2014
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Mar 2014; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT02052141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052141.